骨骼转移瘤发展过程中骨破坏的机制。 - Suppr

Suppr

超能文献

Mechanisms of bone destruction in the development of skeletal metastases.

作者信息

Galasko C S

出版信息

Nature. 1976 Oct 7;263(5577):507-8. doi: 10.1038/263507a0.

DOI:10.1038/263507a0

PMID:972697

Abstract

摘要

相似文献

Mechanisms of bone destruction in the development of skeletal metastases.骨骼转移瘤发展过程中骨破坏的机制。

Nature. 1976 Oct 7;263(5577):507-8. doi: 10.1038/263507a0.

Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins.骨骼转移中骨破坏与破骨细胞活化及前列腺素的关系。

Nature. 1976 Oct 7;263(5577):508-10. doi: 10.1038/263508a0.

Bone metastases studied in experimental animals.

Clin Orthop Relat Res. 1981 Mar-Apr(155):269-85.

Skeletal metastases and mammary cancer.骨骼转移瘤与乳腺癌

Ann R Coll Surg Engl. 1972 Jan;50(1):3-28.

[Pathophysiology of bone metastases in urologic carcinomas].[泌尿系统肿瘤骨转移的病理生理学]

Urologe A. 2007 Aug;46(8):888-90. doi: 10.1007/s00120-007-1519-y.

Acidic microenvironment created by osteoclasts causes bone pain associated with tumor colonization.破骨细胞产生的酸性微环境会引发与肿瘤定植相关的骨痛。

J Bone Miner Metab. 2007;25(2):99-104. doi: 10.1007/s00774-006-0734-8. Epub 2007 Feb 26.

[Role of osteoclasts in the physiopathological mechanisms of malignant osteolysis].破骨细胞在恶性骨溶解病理生理机制中的作用

Bull Cancer. 1993;80(10 Suppl):11-5.

Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits.消炎痛对兔VX2癌所致前列腺素、破骨细胞及骨破坏的控制时机

Br J Cancer. 1979 Sep;40(3):360-4. doi: 10.1038/bjc.1979.189.

Bone metastases studied by experimental models.通过实验模型研究的骨转移

Schweiz Med Wochenschr. 1981 Dec 5;111(49):1862-8.

Bone resorption and bone metastasis risk.骨吸收和骨转移风险。

Med Hypotheses. 2018 Sep;118:36-41. doi: 10.1016/j.mehy.2018.06.013. Epub 2018 Jun 18.

引用本文的文献

Features of Spinal Metastases: A Retrospective View.脊柱转移瘤的特征：回顾性观察

Int J Spine Surg. 2021 Feb;15(1):119-129. doi: 10.14444/8016. Epub 2021 Feb 12.

Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.发挥 OPG 在骨肿瘤学中的多功能作用：平衡 RANKL 和 TRAIL 信号及其他作用。

Clin Exp Metastasis. 2020 Feb;37(1):13-30. doi: 10.1007/s10585-019-09997-8. Epub 2019 Oct 1.

Establishment of successively transplantable rabbit VX2 cancer cells that express enhanced green fluorescent protein.建立表达增强型绿色荧光蛋白的可连续移植的兔VX2癌细胞。

Med Mol Morphol. 2015 Mar;48(1):13-23. doi: 10.1007/s00795-014-0071-2. Epub 2014 Feb 27.

Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid.唑来膦酸治疗骨转移患者血清和龈沟液中核因子-κB 配体和骨保护素水平。

Med Oncol. 2014 Mar;31(3):837. doi: 10.1007/s12032-013-0837-8. Epub 2014 Jan 22.

Physiopathology of spine metastasis.脊柱转移瘤的病理生理学

Int J Surg Oncol. 2011;2011:107969. doi: 10.1155/2011/107969. Epub 2011 Aug 10.

Molecular mechanisms of metastasis in prostate cancer.前列腺癌转移的分子机制

Asian J Androl. 2009 Jan;11(1):57-67. doi: 10.1038/aja.2008.29. Epub 2008 Dec 1.

Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.核因子κB受体活化因子配体与骨保护素在健康与疾病状态下对骨重塑的调节作用

Endocr Rev. 2008 Apr;29(2):155-92. doi: 10.1210/er.2007-0014. Epub 2007 Dec 5.

Malignant melanoma and bone resorption.恶性黑色素瘤与骨吸收。

Br J Cancer. 2006 May 22;94(10):1496-503. doi: 10.1038/sj.bjc.6603103.

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].口服氯膦酸盐辅助治疗可手术乳腺癌可减少骨复发并提高生存率[ISRCTN83688026]

Breast Cancer Res. 2006;8(2):R13. doi: 10.1186/bcr1384. Epub 2006 Mar 15.

Efficacy of oral etidronate for skeletal diseases in Japan.口服依替膦酸在日本治疗骨骼疾病的疗效。

Yonsei Med J. 2005 Jun 30;46(3):313-20. doi: 10.3349/ymj.2005.46.3.313.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验